Superworth

Orchestra BioMed EPS OBIO

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Last 12 months, to Jun 30, 2026
−$1.01
Latest quarter, Q2 FY26
−$0.38
Fiscal year 2025
−$1.29

Orchestra BioMed's earnings per share was −$1.01 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.38.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.29n/a
FY2024−$1.66n/a
FY2023−$1.49n/a
FY2022−$2.38n/a
FY2021−$0.01n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.38n/a−$1.01
Q1 FY26−$0.33n/a−$1.13
Q4 FY25$0.10n/a−$1.29
Q3 FY25−$0.40n/a−$1.81
Q2 FY25−$0.50n/a−$1.82
Q1 FY25−$0.49n/a−$1.77
Q4 FY24−$0.42n/a−$1.66
Q3 FY24−$0.41n/a−$1.60
Q2 FY24−$0.45n/a−$1.57
Q1 FY24−$0.38n/a−$1.47
Q4 FY23−$0.36n/a−$1.49
Q3 FY23−$0.38n/a−$1.61

Against its peers

Companies in Medical - Instruments & Supplies nearest Orchestra BioMed's size, closest first, today.

CompanyEPS, 12 monthsGrowth
OBIOOrchestra BioMed−$1.01
EMBCEmbecta$1.47+3% a year
INFUInfuSystem$0.41+78% a year
UTMDUtah Medical Products$3.28−12% a year
TCMDTactile Systems Technology$1.08+74% a year
PDEXPro DEX$4.11+52% a year
MDXGMimedx$0.04−81% a year
MOVMovado$1.80+137% a year
IRMDIradimed$1.79+10% a year
STAAStaar Surgical$0.07
KEQUKewaunee Scientific$2.76−33% a year
Peer median$1.63

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Orchestra BioMed

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.